FGEN Fibrogen Inc

FibroGen Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs.

$13.44  -0.32 (-2.33%)
As of 12/03/2021 11:54:03 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/14/2014
Outstanding shares:  92,709,943
Average volume:  1,147,310
Market cap:   $1,172,780,779
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    31572Q808
ISIN:        US31572Q8087
Sedol:      BSDRYR8
Valuation   (See tab for details)
PE ratio:   -5.95
PB ratio:   3.92
PS ratio:   4.13
Return on equity:   -65.86%
Net income %:   -75.62%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy